Monokine gene expression in normal human liver: selective involvement of the portal compartment.
暂无分享,去创建一个
P. Galanaud | O. Devergne | D. Émilie | M. Crevon | E. Navratil | M. Reynés | D. Samuel
[1] J. Trapani,et al. Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients. , 1991, AIDS.
[2] M. Peuchmaur,et al. In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. , 1991, Human pathology.
[3] N. Brousse,et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.
[4] J. Gauldie,et al. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. , 1990, Journal of immunology.
[5] D. Hazuda,et al. Processing of precursor interleukin 1 beta and inflammatory disease. , 1990, The Journal of biological chemistry.
[6] P. Heinrich,et al. Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. , 1990, European journal of biochemistry.
[7] M. Röllinghoff,et al. IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor. , 1990, Journal of immunology.
[8] M. Peuchmaur,et al. IL-2 mRNA expression in Tac-positive malignant lymphomas. , 1990, The American journal of pathology.
[9] M. T. Brewer,et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.
[10] Robert C. Thompson,et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.
[11] G. Ciliberto,et al. Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6. , 1989, The EMBO journal.
[12] L. Vanhaelst,et al. Localization of interleukin 6 mRNA in human tonsils by in situ hybridization , 1989, European journal of immunology.
[13] R. Cortese,et al. Interleukin 6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .
[15] P. Heinrich,et al. Fate and biological action of human recombinant interleukin 1β in the rat in vivo , 1989, European journal of immunology.
[16] T. Kishimoto,et al. The biology of interleukin-6. , 1989, Blood.
[17] R. Cortese,et al. The human haptoglobin gene promoter: interleukin‐6‐responsive elements interact with a DNA‐binding protein induced by interleukin‐6. , 1989, The EMBO journal.
[18] L. Moldawer,et al. Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. , 1989, Journal of immunology.
[19] T. Hirano,et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. , 1989, Journal of immunology.
[20] W. Fiers,et al. Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. , 1988, Journal of immunology.
[21] G. Ramadori,et al. Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐α , 1988 .
[22] F. Houssiau,et al. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. , 1988, Arthritis and rheumatism.
[23] W. M. Weaver,et al. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. , 1988, Journal of immunology.
[24] T. Hirano,et al. Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins , 1988 .
[25] T. Hirano,et al. Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.
[26] A. C. Webb,et al. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. , 1988, Journal of immunology.
[27] J. Emond,et al. LIVER TRANSPLANTATION WITH REDUCED‐SIZE DONOR ORGANS , 1988, Transplantation.
[28] J. Gauldie,et al. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.
[29] P. Sehgal,et al. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts , 1987, The Journal of experimental medicine.
[30] C. Hack,et al. SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES , 1987, The Lancet.
[31] M. Lefranc,et al. A gamma 3 hinge region probe: first specific human immunoglobulin subclass probe , 1986, FEBS letters.
[32] C. Milstein,et al. Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. , 1981, Nucleic acids research.
[33] D. Mason,et al. The labeled antigen method of immunoenzymatic staining. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] H. Thomas,et al. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. , 1973, Lancet.
[35] B. Beutler,et al. The essential role of the UA-rich sequence in endotoxin-induced cachectin/TNF synthesis. , 1990, European cytokine network.
[36] C. Dinarello. Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.